Knight Therapeutics | GUD - 股本和储备



金融业
股票价格
CAD
资产
CAD 1.05B
现金及等价物
CAD 76.45M
销售成本
CAD 82.22M
流动资产
CAD 394.84M
流动负债
CAD 165.26M
债务
CAD 77.91M
EBIT
CAD 6.21M
EBITDA
CAD 24.45M
员工
698
EPS每股收益
CAD 0.13
股本和储备
CAD 767.27M
销售毛利
CAD 64.72M
债务利息支出
CAD 3.92M
利息收入
CAD 2.46M
贷款资金
CAD 57.78M
市值
CAD 982.36M
净收入
CAD -3.79M
营业费用
CAD 126.9M
营业利润
CAD 6.21M
普通股股本
CAD 99.68M
PE价格收益
257.34
税前利润
CAD -1.92M
销售收入
CAD 133.11M
销售和管理费用
CAD 35.45M
股票
CAD 95.4M
贸易债权人
CAD 125.76M
应收帐款人
CAD 183M


股本和储备 更改 日
Acasti Pharma USD 64.89M 2.07M 2025-12
Akebia Therapeutics USD 25.02M 2.36M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
Aurora Cannabis CAD 511.83M 24.53M 2026-03
Avita Medical AUD -16.65M 3.76M 2025-12
Canopy Growth CAD 697.59M 60.58M 2026-03
Cronos Group USD 1.07B 4.99M 2026-06
Dianthus Therapeutics USD 1.17B 29.29M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
Moderna USD 6.76B 647M 2026-06
Omeros USD -228.68M 15.13M 2025-06
Organigram Holdings CAD 371.81M 2.36M 2026-03
Organon & Co USD 903M 151M 2026-03
Revvity USD 7.18B 67.62M 2026-03
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Viatris USD 14.26B 397.3M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06